The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, W.
Right arrow Articles by Lehrer, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, W.
Right arrow Articles by Lehrer, R. I.
The Journal of Immunology, 2003, 170: 4708-4716.
Copyright © 2003 by The American Association of Immunologists

Retrocyclin, an Antiretroviral {theta}-Defensin, Is a Lectin1

Wei Wang*, Alexander M. Cole*, Teresa Hong*, Alan J. Waring*,{dagger} and Robert I. Lehrer2,*,{ddagger}

Departments of * Medicine and {dagger} Pediatrics and {ddagger} Molecular Biology Institute, University of California, Los Angeles, CA 90095

{theta}-Defensins are circular octadecapeptides that contain an internal tridisulfide ladder. Because retrocyclin-1, an ancestral hominid {theta}-defensin, can protect human cells in vitro from infection by T- and M-tropic strains of HIV-1, we used surface plasmon resonance techniques to study its binding to glycoproteins and glycolipids implicated in HIV-1 entry. Retrocyclin-1 bound with high affinity to gp120 (Kd, 35.4 nM), CD4 (Kd, 31 nM), and galactosylceramide (Kd, 24.1 nM). Neither a circular form of retrocyclin without its tridisulfide ladder nor its {beta}-hairpin precursor with these disulfides intact bound gp120 or CD4 effectively. Retrocyclin also bound fetuin, an extensively glycosylated protein, with high affinity, but it did not bind nonglycosylated gp120 or BSA. However, retrocyclin did bind to a neoglycoprotein, BSA, with covalently attached sugar residues. Experiments with glycosidase-treated fetuin, gp120, and CD4 revealed that both O-linked and N-linked sugars were used as binding sites. In a panel of retrocyclin variants, binding to immobilized gp120 and CD4 were highly correlated to each other and to the peptide’s ability to protect human PBMCs from infection by HIV-1. Although small, cysteine-rich antimicrobial peptides with lectin-like properties exist in plants, {theta}-defensins are the first such molecules to be identified in vertebrates. Retrocyclin’s ability to recognize and bind carbohydrate-containing surface molecules is integrally related to its ability to protect cells from HIV-1 infection.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Wei, E. de Leeuw, M. Pazgier, W. Yuan, G. Zou, J. Wang, B. Ericksen, W.-Y. Lu, R. I. Lehrer, and W. Lu
Through the Looking Glass, Mechanistic Insights from Enantiomeric Human Defensins
J. Biol. Chem., October 16, 2009; 284(42): 29180 - 29192.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. I. Lehrer, G. Jung, P. Ruchala, W. Wang, E. D. Micewicz, A. J. Waring, E. J. Gillespie, K. A. Bradley, A. J. Ratner, R. F. Rest, et al.
Human {alpha}-Defensins Inhibit Hemolysis Mediated by Cholesterol-Dependent Cytolysins
Infect. Immun., September 1, 2009; 77(9): 4028 - 4040.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. I. Lehrer, G. Jung, P. Ruchala, S. Andre, H. J. Gabius, and W. Lu
Multivalent Binding of Carbohydrates by the Human {alpha}-Defensin, HD5
J. Immunol., July 1, 2009; 183(1): 480 - 490.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Doss, M. R. White, T. Tecle, D. Gantz, E. C. Crouch, G. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, and K. L. Hartshorn
Interactions of {alpha}-, {beta}-, and {theta}-Defensins with Influenza A Virus and Surfactant Protein D
J. Immunol., June 15, 2009; 182(12): 7878 - 7887.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. E. Garcia, G. Osapay, P. A. Tran, J. Yuan, and M. E. Selsted
Isolation, Synthesis, and Antimicrobial Activities of Naturally Occurring {theta}-Defensin Isoforms from Baboon Leukocytes
Infect. Immun., December 1, 2008; 76(12): 5883 - 5891.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. E. Dietrich, X. Xiao, D. V. Dawson, M. Belanger, H. Xie, A. Progulske-Fox, and K. A. Brogden
Human {alpha}- and {beta}-Defensins Bind to Immobilized Adhesins from Porphyromonas gingivalis
Infect. Immun., December 1, 2008; 76(12): 5714 - 5720.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Wang, K. M. Watson, and R. W. Buckheit Jr.
Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3438 - 3440.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Bultmann, J. Teuton, and C. R. Brandt
Addition of a C-Terminal Cysteine Improves the Anti-Herpes Simplex Virus Activity of a Peptide Containing the Human Immunodeficiency Virus Type 1 TAT Protein Transduction Domain
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1596 - 1607.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Teuton and C. R. Brandt
Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells
J. Virol., April 15, 2007; 81(8): 3731 - 3739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wang, C. Mulakala, S. C. Ward, G. Jung, H. Luong, D. Pham, A. J. Waring, Y. Kaznessis, W. Lu, K. A. Bradley, et al.
Retrocyclins Kill Bacilli and Germinating Spores of Bacillus anthracis and Inactivate Anthrax Lethal Toxin
J. Biol. Chem., October 27, 2006; 281(43): 32755 - 32764.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
B. Grubor, D. K. Meyerholz, and M. R. Ackermann
Collectins and cationic antimicrobial peptides of the respiratory epithelia.
Vet. Pathol., September 1, 2006; 43(5): 595 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Gallo, W. Wang, S. S. Rawat, G. Jung, A. J. Waring, A. M. Cole, H. Lu, X. Yan, N. L. Daly, D. J. Craik, et al.
{theta}-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation
J. Biol. Chem., July 7, 2006; 281(27): 18787 - 18792.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
H. Jenssen, P. Hamill, and R. E. W. Hancock
Peptide Antimicrobial Agents
Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Cole, O. O. Yang, A. D. Warren, A. J. Waring, R. I. Lehrer, and A. M. Cole
HIV-1 Adapts to a Retrocyclin with Cationic Amino Acid Substitutions That Reduce Fusion Efficiency of gp41.
J. Immunol., June 1, 2006; 176(11): 6900 - 6905.
[Abstract] [Full Text] [PDF]


Home page
ADRHome page
A. Weinberg, M.E. Quinones-Mateu, and M.M. Lederman
Role of Human {beta}-defensins in HIV Infection
Advances in Dental Research, April 1, 2006; 19(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Sun, C. M. Finnegan, T. Kish-Catalone, R. Blumenthal, P. Garzino-Demo, G. M. La Terra Maggiore, S. Berrone, C. Kleinman, Z. Wu, S. Abdelwahab, et al.
Human {beta}-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection
J. Virol., November 15, 2005; 79(22): 14318 - 14329.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. E. VanCompernolle, R. J. Taylor, K. Oswald-Richter, J. Jiang, B. E. Youree, J. H. Bowie, M. J. Tyler, J. M. Conlon, D. Wade, C. Aiken, et al.
Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells
J. Virol., September 15, 2005; 79(18): 11598 - 11606.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Sang, M. T. Ortega, F. Blecha, O. Prakash, and T. Melgarejo
Molecular Cloning and Characterization of Three {beta}-Defensins from Canine Testes
Infect. Immun., May 1, 2005; 73(5): 2611 - 2620.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. Ericksen, Z. Wu, W. Lu, and R. I. Lehrer
Antibacterial Activity and Specificity of the Six Human {alpha}-Defensins
Antimicrob. Agents Chemother., January 1, 2005; 49(1): 269 - 275.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Patil, A. L. Hughes, and G. Zhang
Rapid evolution and diversification of mammalian {alpha}-defensins as revealed by comparative analysis of rodent and primate genes
Physiol Genomics, December 15, 2004; 20(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Tanabe, A. J. Ouellette, M. J. Cocco, and W. E. Robinson Jr.
Differential Effects on Human Immunodeficiency Virus Type 1 Replication by {alpha}-Defensins with Comparable Bactericidal Activities
J. Virol., November 1, 2004; 78(21): 11622 - 11631.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
O. Levy
Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes
J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
P. Roch, A. Beschin, and E. Bernard
Antiprotozoan and Antiviral Activities of Non-cytotoxic Truncated and Variant Analogues of Mussel Defensin
Evid. Based Complement. Altern. Med., September 1, 2004; 1(2): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Wang, S. M. Owen, D. L. Rudolph, A. M. Cole, T. Hong, A. J. Waring, R. B. Lal, and R. I. Lehrer
Activity of {alpha}- and {theta}-Defensins against Primary Isolates of HIV-1
J. Immunol., July 1, 2004; 173(1): 515 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. B. Medeiros, R. d. O. Resende, and A. C. de Avila
The Plant Virus Tomato Spotted Wilt Tospovirus Activates the Immune System of Its Main Insect Vector, Frankliniella occidentalis
J. Virol., May 15, 2004; 78(10): 4976 - 4982.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Yasin, W. Wang, M. Pang, N. Cheshenko, T. Hong, A. J. Waring, B. C. Herold, E. A. Wagar, and R. I. Lehrer
{theta} Defensins Protect Cells from Infection by Herpes Simplex Virus by Inhibiting Viral Adhesion and Entry
J. Virol., May 15, 2004; 78(10): 5147 - 5156.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Teleshova, I. Frank, and M. Pope
Immunodeficiency virus exploitation of dendritic cells in the early steps of infection
J. Leukoc. Biol., November 1, 2003; 74(5): 683 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.